GlassScriptPhysician profile
Lopa M Patel
NPI 1447268677
$9,864.54
in general payments reported to CMS, 2019-2025
34 companies · $1,332 in 2025
The $1,332 reported for 2025 was more than what 82% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $120 · 2021: $419 · 2022: $862 · 2023: $1,422 · 2024: $5,152 · 2025: $1,332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,005 · Education: $2,500 · Travel and Lodging: $1,391 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,005.40 |
| Education | $2,500.00 |
| Travel and Lodging | $1,390.77 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,172.06 | 2024 | |
| Glaxosmithkline, LLC. | $1,607.78 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,256.48 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $440.69 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Insmed, INC. | $349.35 | 2022-2025 | Arikayce, Brinsupri |
| Harmony Biosciences LLC | $265.35 | 2021-2025 | Wakix |
| Medtronic, INC. | $197.06 | 2023 | |
| Mylan Specialty L.P. | $188.97 | 2019-2024 | Yupelri |
| Axsome Therapeutics, INC. | $151.42 | 2023-2025 | Sunosi |
| Philips North America LLC | $145.95 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Amgen INC. | $142.31 | 2022-2025 | Tezspire |
| Jazz Pharmaceuticals INC. | $130.39 | 2019-2024 | |
| Pulmonx Corporation | $114.84 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Viatris Specialty LLC | $74.91 | 2025 | Yupelri |
| Sanofi-Aventis U.S. LLC | $74.75 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $70.44 | 2019 | |
| Mallinckrodt Hospital Products INC. | $65.05 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $45.92 | 2022-2023 | |
| Shire North American Group INC | $43.55 | 2019 | |
| Baxter Healthcare | $37.75 | 2025 | Hillrom - Monarch Airway Clearance System |
| Vifor Pharma, INC. | $31.56 | 2024-2025 | Zemaira |
| Regeneron Healthcare Solutions, INC. | $31.17 | 2019-2025 | Dupixent |
| Avadel Cns Pharmaceuticals, LLC | $30.52 | 2025 | Lumryz |
| Horizon Therapeutics Plc | $29.00 | 2019-2020 | |
| Grifols USA, LLC | $28.96 | 2019-2025 | Prolastin-C Liquid |
| Lilly USA, LLC | $22.22 | 2025 | Zepbound |
| United Therapeutics Corporation | $20.58 | 2021 | |
| Verona Pharma, INC. | $17.40 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $17.13 | 2023 | |
| Covidien LP | $13.87 | 2019 | |
| Optinose US, INC. | $12.59 | 2021 | |
| Genzyme Corporation | $11.67 | 2019 | |
| Circassia INC. | $11.53 | 2019 | |
| Mallinckrodt Enterprises LLC | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lopa Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.